Literature DB >> 23776341

Congenital chloride diarrhea: a review of twelve Arabian children.

Fawaz Elrefae1, Ahmed Farag Elhassanien, Hesham Abdel-Aziz Alghiaty.   

Abstract

BACKGROUND: Congenital chloride diarrhea (CCD), a rare autosomal recessive disorder, is characterized by sustained watery diarrhea (due to defect of active Chloride/HCO3 exchange in the ileum and colon) with high fecal chloride.
OBJECTIVE: To spotlight the common presentation of CCD for early management and prevention of complications. SUBJECTS AND METHODS: This is a retrospective case series study of patients diagnosed as CCD who were followed up in the pediatric department of Al-Adan Hospital, Kuwait.
RESULTS: Twelve patients diagnosed with CCD were born to consanguineous parents; had antenatal history of intrauterine growth retardation (IUGR); polyhydramnios; and distended hypoechoic fetal bowel; and presented with abdominal distension, hypotonia and muscle wasting. 90% of patients had maternal hypertension and 75% of patients had absence of normal meconium at birth. Our patients showed a decrease in serum sodium, potassium, chloride and urine chloride.
CONCLUSION: A high level of suspicion for an early diagnosis of CCD should be considered for any infant presenting with chronic diarrhea, especially in the presence of consanguineous marriage, and the characteristic features in antenatal ultrasound. Thus, allowing for early investigations and appropriate management.

Entities:  

Keywords:  children; chronic diarrhea; congenital chloride diarrhea; metabolic alkalosis; prenatal diagnosis

Year:  2013        PMID: 23776341      PMCID: PMC3681327          DOI: 10.2147/CEG.S40620

Source DB:  PubMed          Journal:  Clin Exp Gastroenterol        ISSN: 1178-7023


Introduction

Congenital chloride diarrhea (CCD) is a rare, genetically determined cause of persistent, life threatening, watery diarrhea, which is characterized by excessive chloride loss in stools. CCD is an autosomal recessive disorder. Most cases have been reported in Finland and the Middle East.1–3 Gamble et al,4 and Darrow5 first described the condition in 1945. Recently, the CCD gene has been accurately located on chromosome 7.6 Most children with CCD are born preterm and their antenatal ultrasound usually reveal polyhydramnios with significant dilatation of the fetal intestinal loops.7 Postnatally, these children exhibit significant abdominal distension, profuse and watery stools, and failure to thrive. Some infants survive for several months without diagnosis but any intercurrent infection, particularly gastroenteritis, disturbing the delicate water and electrolyte balance can lead to their demise.8 Hyponatremia, hypokalemia, hypochloremia, and metabolic alkalosis are features of the disease. High fecal chloride (>100 mmol/L), exceeding the sum of fecal sodium and potassium and a chloride-free urine confirm the diagnosis.9 Since the intestinal defect cannot be corrected, life-long treatment with both sodium and potassium chloride solutions is required. With early diagnosis and adequate treatment children with CCD can achieve normal physical growth and mental development.10

Aim of the work

The aim of our study is to spotlight antenatal and early neonatal diagnosis of infants with congenital chloride diarrhea which appears not to be an uncommon disorder in Kuwait and Arabian Peninsula for early management and prevention of complications.

Patients and methods

The inpatient database of the Pediatric Department at Al-Adan Hospital, Kuwait was broadly searched for patients with the diagnosis of chronic diarrhea presented in the first year of life. Sixty-seven cases diagnosed between January 2006 and January 2011 were identified. The diagnosis of CCD was based on antenatal onset of clinical presentation and laboratory finding of excess chloride loss in stool and low serum chloride level. Of the 67 patients, twelve patients fulfilled the diagnostic criteria for CCD (seven females and five males). Their ages at diagnosis ranged from antenatal up to 8 months. Seventeen out of 55 were diagnosed as infectious diarrhea, 33 patients as cow’s milk protein allergy, three patients as celiac disease, one patient as congenital enteropathy, and one patient as galactose–glucose malabsorption. Medical records of the patients was obtained from the inpatient medical records. The following data were extracted; history of previous fetal loss, antenatal history (polyhydramnios, maternal hypertension, fetal abdominal distension, distended hypoechoic fetal bowel, intrauterine growth retardation [IUGR]), neonatal history (gestational age, birth weight, prematurity, absence of meconium at birth), age of onset of diarrhea, and age of diagnosis, presenting complaint (diarrhea, loose stool, abdominal distension). Laboratory data were extracted from laboratory reports and progress notes in the individual charts. The laboratory data collected from the files at the time of presentation were; serum electrolytes, serum bicarbonate, blood pH, urine chloride, stool electrolytes, serum aldosterone, and plasma rennin activity. Antenatal ultrasonography reports were available for nine patients. In the cases of available antenatal ultrasonography, radiological and gynecological reports were reviewed. SPSS program version 11 (IBM Corporation, Armonk, NY, USA) was used to analyze patient data. Descriptive statistics and t-test were used to analyze the data.

Results

Twelve patients were diagnosed as CCD; seven females (58.3%) and five males (41.7%). All twelve patients were born to consanguineous parents and two of them were siblings. Antenatal diagnosis was made in four cases, three patients were diagnosed in the neonatal period three at 2 months, one at 4 months, and one at 8 months of age. Antenatal diagnosis was based on the presence of maternal polyhydramnios, hypertension, and ultrasonographic findings. Ten patients were delivered prematurely (83.33%). All patients (100%) had IUGR, polyhydramnios, and distended hypoechoic fetal bowel but eight patients (66.6%) had maternal hypertension, and nine patients (75%) had fetal abdominal distension. A family history of fetal loss was obtained in six cases (50%). As regards clinical presentation; nine patients (75%) showed absence of normal meconium at birth, six patients (50%) showed stool-like urine and four patients (33.3%) showed abdominal distension. Mild to moderate abdominal distension, hypotonia, and muscle wasting were present in all patients at the time of admission. In the eight patients with long-term follow-up, weight and linear and head circumference growth have been satisfactory. There had been no developmental delays. Two patients had renal tubular dysfunction after their first year of life. The laboratory investigations of our patients were compared with that of patients diagnosed as cow’s milk protein allergy. Patients with CCD showed significant decrease in serum potassium (P = 0.001), serum chloride (P = 0.001) and urine chloride (P = 0.001) compared with that of patients with cow’s milk protein allergy. Whereas serum bicarbonates and stool chloride were significantly increased in our patients with CCD (P = 0.001). Our CCD patients showed high stool chloride loss as evidenced by increased ratio stool Cl/serum Cl (1.875 ± 0.508) and stool Cl/Na + K ratio (1.35 ± 0.6274). Increased plasma rennin activity (61.166 ± 15.95) and serum aldosterone (1538 ± 1133), were observed also in our CCD patients.

Discussion

Congenital chloride diarrhea is a rare intestinal disorder affecting electrolyte transportation, presenting clinically with a persistent life-threatening diarrhea with high fecal chloride content (>90 mmol/L).1,2 It is inherited as an autosomal recessive disorder with its gene located on chromosome 7.6 Since the first case report of CCD published by Gamble et al,4 and Darrow5 in 1945, more than 140 cases have been recognized all over the world. The incidence of CCD was established to be 1/14,000 in Kuwait 2 compared to that of Finland 1/43,000.1 This high incidence in Kuwait may be due to the multigenerational practice of consanguineous marriage and the autosomal recessive manner of inheritance of the disease. Consanguinity was a constant feature in our cases. Before 31 weeks of gestation, maternal polyhydramnios was evident in all patients (100%), which should attract the attention of obstetricians to the possibility of a CCD affected baby, especially in the presence of distended fetal hypoechoic bowel (Figure 1A and B). This polyhydramnios can be explained presumably by intrauterine diarrhea. The other factors supporting the antenatal diagnosis of CCD were presence of maternal hypertension (eight cases [66.6%]), fetal abdominal distension (nine patients [75%]), and family history of fetal loss (six cases [50%]). These mothers had no hypertension either before or during previous pregnancies, and this high blood pressure settled down after labor. So it seems that maternal hypertension is secondary to the fetal illness, most probably due to high fetal rennin9 but this association remains to be established.
Figure 1

Antenatal ultrasounds. (A and B) show antenatal ultrasounds of two patients with distended fetal hypoechoic intestinal loops.

Fetal abdominal distension (due to fluid accumulating in their intestine)7 can be considered pathognomonic for CCD, however dilated bowel loops could be present in other diseases like cystic fibrosis or intestinal obstruction. However, in cystic fibrosis, the dilated bowel loops are hyperechoic due to the viscosity of meconium11 and in intestinal obstruction dilated intestinal loops is associated with increased peristalsis in few dilated bowel loops.12 After delivery, our patients showed watery diarrhea, usually in the early neonatal period in ten patients (83.33%), and after the neonatal period in two patients (16.66%). The diagnosis is often delayed as neonatal stools are usually mistaken as urine. Other features supporting the diagnosis were prematurity in ten patients (83.33%), IUGR in all patients (100%), lack of meconium at birth observed in nine patients (75%), and abdominal distention in four patients (33.3%). In CCD, there is absence or impairment of active chloride/bicarbonate exchange in both the ileum and colon. The defective chloride absorption leads to osmotic diarrhea. This malabsorption also explains the metabolic abnormalities seen in these patients.8 Serum electrolytes in our patients before treatment showed hyponatremia, hypokalemia, hypochloremia, and metabolic alkalosis (Table 2). Diagnosis was confirmed by high stool chloride concentration and high stool/serum chloride ratio. Concurrent urine chloride concentration was normal or low. Although CCD is characterized by high stool chloride,13 lower fecal chloride content has been reported among infants with severe dehydration as well as in neonates.11 In those patients the ratio of stool Chloride/Na + K is more valuable in the diagnosis of CCD. The mean value in normal stools is 0.2413, while in our patients the mean value was 1.35 (range = 0.5–2.3). Fecal/serum chloride ratio was also significantly elevated (1.87) expressing the magnitude of fetal chloride losses (Table 2).
Table 2

Comparison of demographic and laboratory data of congenital chloride diarrhea and cow’s milk protein allergy patients

CCD patients (n = 12)Cow’s milk protein allergy patients (n = 33)P-value
Serum Na131.75 ± 5.01134 ± 4.030.059
Serum K2.708 ± 0.363.6 ± 1.90.001*
Serum Cl77.98 ± 16.21105 ± 5.80.001*
Serum HCO336 ± 6.36723 ± 3.20.001*
Blood pH7.4025 ± 0.127.31 ± 0.50.02*
Stool Cl (20 ± 4 mmol/L)150 ± 55.114.5 ± 2.40.001*
Stool Cl/serum Cl (0.2)1.875 ± 0.5080.185 ± 0.060.001*
Urine Cl (8–30 mmol/L)7.5833 ± 6.097121.3 ± 3.20.001*

Note:

significant if P < 0.05.

Abbreviation: CCD, congenital chloride diarrhea.

Since the intestinal defect cannot be corrected, lifelong treatment with both sodium and potassium chloride solutions is required. The rationale behind this therapy is the normal jejunal absorption of these electrolytes. Such treatment will not correct the diarrhea but will prevent its secondary effects. With early diagnosis and adequate treatment, children with CCD can achieve normal physical growth and mental development. Treatment of our patients started by adequate replacement of chloride with sodium and potassium salts, initially intravenously and subsequently orally. Oral therapy was started in our patients within 24 to 48 hours of admission. The dose was titrated to ensure adequate urinary chloride concentration of .30 mmol/L (indicator of normal extracellular fluid volume and adequacy of the chloride substitution dose).14 All patients had excellent clinical responses with increased alertness, weight gain, and increased muscle tone. However, 20% of the cases had developmental delay which may be due to their late diagnosis and treatment.15 The most common complications occurring in those patents were renal tubular dysfunction resulting from chronic hypovolemia and hypokalemia, and volvulus which may occur at any age from 2 days to 15 years.10 Many studies have shown that renal calcium deposits with arrested renal growth and impaired renal function were significant in patients with CCD.15,16 Our patients did not show any impaired renal growth or functions, or evidence of nephrocalcinosis on follow-up, a finding reported also by Kagalwalla3 but this may be due to early diagnosis and receiving adequate therapy.

Conclusion

Diagnosis of CCD must be considered in any newborn presenting with prolonged diarrhea especially in the presence of consanguineous marriage, maternal polyhydramnios, and antenatal hypertension. In these suspected cases antenatal ultrasound should concentrate on characteristic features of the disease in fetal intestine and early investigations and appropriate management should be instituted postnatally.
Table 1

Summary of clinical finding of congenital chloride diarrhea cases

NoSexGA(w)BW (gm)Diarrh age (days)Diagn ageEarly clinical neonatal features
Antenatal features suggesting of CCD
PTIUGRAbs of meconStool like urineAbd distensionH/O fetal lossPolyM hypertFetal abd distensionDistended hypoechoic fetal bowel
1F3516504AN+++++++++
2F3416006AN+++++++++
3F3314507LNP+++++++++
4M34155052 m+++++-+
5M371900454 m+++++++
6M3615606LNNP+++++++
7F32130052 m+++++++
8M402400758 m+++++++
9F4022007LNP++++
10F3617008AN+++++++
11M3415005AN+++++++
12F33145072 m+++++++++
%AN 33.3%83.3%100%75%50%33.33%50%100%66.66%75%100%
LNP 25%
2 m 25%
4 m 8.3%
8 m 8.3%

Abbreviations: CCD, congenital chloride diarrhea; GA, gestational age; H/O, history of; BW, birth weight; Diarrh age, age of onset of diarrhea; Diagn age, age of diagnosis; PT, prematurity; IUGR, intrauterine growth retardation; Abs of mecon, absence of meconium; Abd distension, abdominal distension; Poly, polyhydramnios; M hypert, maternal hypertension; Fetal abd distension, Fetal abdominal distension; AN, antenatal; LNP, late neonatal period; M, months; W, weeks.

  12 in total

1.  The renal lesion in congenital chloride diarrhea.

Authors:  C Holmberg; J Perheentupa; A Pasternack
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

2.  Dilated fetal bowel. A sonographic sign of cystic fibrosis.

Authors:  D A Nyberg; W Hastrup; H Watts; L A Mack
Journal:  J Ultrasound Med       Date:  1987-05       Impact factor: 2.153

3.  Fine mapping of the congenital chloride diarrhea gene by linkage disequilibrium.

Authors:  P Höglund; P Sistonen; R Norio; C Holmberg; A Dimberg; K H Gustavson; A de la Chapelle; J Kere
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

4.  Prenatal ultrasonic findings in congenital chloride diarrhoea.

Authors:  P Kirkinen; P Jouppila
Journal:  Prenat Diagn       Date:  1984 Nov-Dec       Impact factor: 3.050

5.  Congenital chloride diarrhoea. Clinical analysis of 21 Finnish patients.

Authors:  C Holmberg; J Perheentupa; K Launiala; N Hallman
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

6.  Electrolyte economy and its hormonal regulation in congenital chloride diarrhea.

Authors:  C Holmberg
Journal:  Pediatr Res       Date:  1978-02       Impact factor: 3.756

7.  Surgical implications of congenital chloride diarrhoea.

Authors:  K Lundkvist; G Annerén; T Esscher; U Ewald; L I Hardell
Journal:  Z Kinderchir       Date:  1983-08

8.  Congenital chloride diarrhea: A single center experience with ten patients.

Authors:  A Al-Abbad; H Nazer; S A Sanjad; E Al-Sabban
Journal:  Ann Saudi Med       Date:  1995-09       Impact factor: 1.526

9.  Congenital chloride diarrhea. A study in Arab children.

Authors:  A F Kagalwalla
Journal:  J Clin Gastroenterol       Date:  1994-07       Impact factor: 3.062

10.  Congenital chloride diarrhoea in Kuwaiti children.

Authors:  M M Lubani; K I Doudin; D C Sharda; A A Shaltout; T S al-Shab; Y K Abdul Al; M A Said; M M Salhi; S A Ahmed
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

View more
  3 in total

1.  Recurrent Metabolic Alkalosis in a Cystic Fibrosis Patient: Coexistence with Congenital Chloride Diarrhea.

Authors:  Etna Masip; Ester Donat; Begoña Polo; Silvestre Oltra; Pedro Ortega; Carmen Ribes-Koninckx
Journal:  J Pediatr Genet       Date:  2019-09-02

2.  Congenital chloride losing diarrhea: A single center experience in a highly consanguineous population.

Authors:  Naglaa M Kamal; Hekmat Yaqoub Khan; Mortada H F El-Shabrawi; Laila M Sherief
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  Congenital chloride diarrhea clinical features and management: a systematic review.

Authors:  Lavinia Di Meglio; Giuseppe Castaldo; Caterina Mosca; Andrea Paonessa; Monica Gelzo; Maria Valeria Esposito; Roberto Berni Canani
Journal:  Pediatr Res       Date:  2020-11-10       Impact factor: 3.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.